Intchains Group
ICG
SATO TECHNOLOGIES CORP
CCPUF
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
Bitfarms
BITF
US Stock MarketDetailed Quotes
FHTX Foghorn Therapeutics
- 4.820
- -0.270-5.30%
Close Dec 27 16:00 ET
- 4.820
- 0.0000.00%
Post 16:01 ET
267.96MMarket Cap-2.61P/E (TTM)
5.220High4.650Low204.49KVolume5.090Open5.090Pre Close990.64KTurnover0.79%Turnover RatioLossP/E (Static)55.59MShares10.25052wk High-9.47P/B125.58MFloat Cap2.70052wk Low--Dividend TTM26.05MShs Float28.265Historical High--Div YieldTTM11.20%Amplitude2.700Historical Low4.844Avg Price1Lot Size
About Foghorn Therapeutics Company
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Company Profile
SymbolFHTX
Company NameFoghorn Therapeutics
Listing DateOct 23, 2020
Issue Price16.00
Founded2015
CEOMr. Adrian Gottschalk
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address500 Technology Square,Suite 700
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-586-3100
Websitehttp://www.foghorntx.com
Company Executives
- Name
- Position
- Salary
- Adrian Gottschalk
- Chief Executive Officer and Director
- 2.50M
- Kristian F. Humer
- Chief Financial Officer and Principal Accounting Officer
- --
- Fanny Cavalie
- Chief Strategy and Business Operations Officer
- --
- Michael J. LaCascia
- Chief Legal Officer
- --
- Dr. Steven F. Bellon, PhD
- Chief Scientific Officer
- 1.19M
- Dr. Alfonso Quintas-Cardama
- Chief Medical Officer
- 1.84M
- Carlos Costa
- Chief People Officer
- --
- Dr. Douglas G. Cole, M.D.
- Chairman of the Board
- 184.57K
- Dr. Thomas J. Lynch
- Independent Director
- 145.57K
- Dr. Scott Biller, PhD
- Independent Director
- 145.57K
- Dr. Michael Mendelsohn, M.D.
- Independent Director
- 154.57K
- Ian F. Smith
- Independent Director
- 141.57K
- B. Lynne Parshall, Esq.,J.D.
- Independent Director
- 157.65K
- Dr. Balkrishan Gill, PhD
- Independent Director
- 159.07K
- Dr. Adam M. Koppel, M.D.,PhD
- Independent Director
- 153.07K
- Stephen J. DiPalma
- Treasurer
- --
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.